NMPA Approval

Agalsidase Beta for Injection

Approval Number

国药准字SJ20190041

Registration Date

April 25, 2024

Previous Approval Numbers

S20190041

Drug Information

Generic Name

注射用阿加糖酶β

Trade Name

法布赞

Dosage Form

注射剂

Strength

35mg/瓶

Drug Type

生物制品

Registration Date

April 25, 2024

Expiry Date

April 24, 2029

Company NameSanofi B.V.

Company Address

Paasheuvelweg 25,1105 BP Amsterdam, The Netherlands

Company Address

IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland

Empowering clinical research with data-driven insights and AI-powered tools.

注射用阿加糖酶β - NMPA 批准文号 | MedPath